Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical study
Kang, Chang Kyung, Kim, Nak-Hyun, Kim, Chung-Jong, Rhie, Gi-eun, Jo, Su Kyoung, Ahn, Misun, Kang, Jieun, Choe, Pyoeng Gyun, Park, Wan Beom, Kim, Nam-Joong, Oh, Myoung-donLanguage:
english
Journal:
Vaccine
DOI:
10.1016/j.vaccine.2019.05.057
Date:
May, 2019
File:
PDF, 509 KB
english, 2019